2 studies found for:    8527050 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Omalizumab to Treat Hyper-IgE (Job's) Syndrome
Conditions: Hyper-IgE Syndrome;   Job's Syndrome
Intervention: Drug: Omalizumab (Xolair)
2 Completed Omalizumab to Treat Eosinophilic Gastroenteritis
Condition: Gastroenteritis
Intervention: Drug: Omalizumab

Indicates status has not been verified in more than two years